Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amgen Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AMGN
Nasdaq
2830
www.amgen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amgen Inc.
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
- May 7th, 2026 2:01 pm
IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading
- May 7th, 2026 5:34 am
Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates
- May 7th, 2026 4:00 am
As AI Rewrites Drug Development, the Industry Gathers in Philadelphia to Work Out the Rules
- May 6th, 2026 12:11 pm
Amgen’s US$300m Biologics Push And What It Means For AMGN Stock
- May 6th, 2026 10:12 am
RPRX vs. AMGN: Which Stock Is the Better Value Option?
- May 6th, 2026 9:40 am
Timothy P. Walbert Joins Patient Square Capital as a Senior Advisor
- May 6th, 2026 6:00 am
How This Amgen Rival, Up 33%, Plans To Shake Its Grip In Thyroid Eye Disease
- May 5th, 2026 2:24 pm
Viridian data lift prospects for thyroid eye disease drug
- May 5th, 2026 6:04 am
2 Nasdaq 100 Stocks with Competitive Advantages and 1 We Question
- May 5th, 2026 3:48 am
What’s at stake in Amgen’s showdown with the FDA?
- May 5th, 2026 3:09 am
Sector Update: Health Care Stocks Softer in Afternoon Trading
- May 4th, 2026 11:58 am
Amgen invests $300M more in Puerto Rico biologics plant
- May 4th, 2026 8:53 am
Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?
- May 4th, 2026 8:50 am
3 Top Dividend Stocks to Maximize Your Retirement Income
- May 4th, 2026 7:10 am
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
- May 4th, 2026 7:00 am
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR
- May 4th, 2026 7:00 am
Baron Health Care Fund’s Performance Impacted by Amgen (AMGN) Omission
- May 4th, 2026 5:49 am
AMGN Q1 Deep Dive: Growth Drivers Offset Patent Losses, Pipeline Progress in Focus
- May 2nd, 2026 9:16 am
Assessing Amgen (AMGN) Valuation After Recent Share Price Weakness And Pipeline Expectations
- May 1st, 2026 5:11 pm
Scroll